Published in Gen Comp Endocrinol on December 30, 2006
Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes. Endocrinology (1991) 1.30
Dirofilaria infections in working dogs in Slovakia. J Helminthol (2009) 1.17
Review on the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivo. Curr Pharm Des (2011) 1.11
Central retinal vessel trunk exit and location of glaucomatous parapapillary atrophy in glaucoma. Ophthalmology (2001) 1.05
Inhibition by nociceptin of neurogenic inflammation and the release of SP and CGRP from sensory nerve terminals. Br J Pharmacol (1997) 1.03
Immobilization stress may increase plasma interleukin-6 via central and peripheral catecholamines. Neuroimmunomodulation (1995) 1.03
Examination of sensorimotor performance following middle cerebral artery occlusion in rats. Brain Res Bull (2003) 1.03
Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia. Peptides (2002) 1.03
Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptide. Brain Res (1996) 1.02
Primary Sjögren's syndrome from the viewpoint of an internal physician. Int Ophthalmol (1991) 1.00
Loss of pacing-induced preconditioning in rat hearts: role of nitric oxide and cholesterol-enriched diet. J Mol Cell Cardiol (1997) 1.00
Classic preconditioning decreases the harmful accumulation of nitric oxide during ischemia and reperfusion in rat hearts. Circulation (1999) 0.99
Chronomics: circadian lead of extrapineal vs. pineal melatonin rhythms with an infradian hypothalamic exploration. Biomed Pharmacother (2005) 0.97
[Prognostic factors and visual outcome for open globe injuries with intraocular foreign bodies]. Klin Monbl Augenheilkd (2010) 0.96
PACAP is an endogenous protective factor-insights from PACAP-deficient mice. J Mol Neurosci (2012) 0.95
Systemic anti-inflammatory effect induced by counter-irritation through a local release of somatostatin from nociceptors. Br J Pharmacol (1998) 0.94
Characteristics of interstitial lung disease in SS-A positive/Jo-1 positive inflammatory myopathy patients. Rheumatol Int (2009) 0.92
The triple classification of dry eye for practical clinical use. Eur J Ophthalmol (2005) 0.90
Anti-inflammatory effect of synthetic somatostatin analogues in the rat. Br J Pharmacol (2001) 0.90
Comparative distribution of immunoreactive pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide in rat forebrain. Neuroendocrinology (1991) 0.90
Immunohistochemical demonstration of a novel hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide, in the ovine hypothalamus. Endocrinology (1990) 0.89
Pituitary adenylate cyclase activating polypeptide protects cardiomyocytes against oxidative stress-induced apoptosis. Peptides (2005) 0.89
A case of paradoxical worsening of dural-sinus arteriovenous malformation syndrome after neurosurgery. Eur J Ophthalmol (1996) 0.89
Chronomics affirm extending scope of lead in phase of duodenal vs. pineal circadian melatonin rhythms. Biomed Pharmacother (2005) 0.89
Capsaicin-sensitive local sensory innervation is involved in pacing-induced preconditioning in rat hearts: role of nitric oxide and CGRP? Naunyn Schmiedebergs Arch Pharmacol (1997) 0.89
Anti-nociceptive effect induced by somatostatin released from sensory nerve terminals and by synthetic somatostatin analogues in the rat. Neurosci Lett (2000) 0.89
Cholecystokinin fails to promote pancreatic regeneration in diabetic rats following the induction of experimental pancreatitis. Pharmacol Res (2001) 0.88
Conversion formulas between automated-perimetry indexes as measured by two different types of instrument. Ophthalmologica (2001) 0.87
Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects. Ann N Y Acad Sci (2010) 0.87
Rapid pacing-induced preconditioning is recaptured by farnesol treatment in hearts of cholesterol-fed rats: role of polyprenyl derivatives and nitric oxide. Mol Cell Biochem (1998) 0.87
Delayed cardiac protection against harmful consequences of stress can be induced in experimental atherosclerosis in rabbits. J Mol Cell Cardiol (1997) 0.87
Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) are more susceptible to retinal ischemic injury in vivo. Neurotox Res (2011) 0.86
Release of somatostatin and its role in the mediation of the anti-inflammatory effect induced by antidromic stimulation of sensory fibres of rat sciatic nerve. Br J Pharmacol (1998) 0.86
7-oxo-PgI2 induced late appearing and long-lasting electrophysiological changes in the heart in situ of the rabbit, guinea-pig, dog and cat. J Mol Cell Cardiol (1989) 0.86
Types of atrophic gastritis in patients with primary Sjögren's syndrome. Ann Rheum Dis (1991) 0.86
Lack of correlation between myocardial nitric oxide and cyclic guanosine monophosphate content in both nitrate-tolerant and -nontolerant rats. Biochem Pharmacol (1998) 0.85
Regional differences in nitric oxide-mediated relaxation of the rabbit sphincter of Oddi. Eur J Pharmacol (1994) 0.85
Diazoxide is protective in the rat retina against ischemic injury induced by bilateral carotid occlusion and glutamate-induced degeneration. Neurotox Res (2007) 0.83
PKA-Bad-14-3-3 and Akt-Bad-14-3-3 signaling pathways are involved in the protective effects of PACAP against ischemia/reperfusion-induced cardiomyocyte apoptosis. Regul Pept (2007) 0.83
Transport of pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier and the prevention of ischemia-induced death of hippocampal neurons. Ann N Y Acad Sci (1996) 0.83
Protective effects of pituitary adenylate cyclase activating polypeptide in endothelial cells against oxidative stress-induced apoptosis. Gen Comp Endocrinol (2006) 0.83
[Ultrasonographic findings in endophthalmitis following cataract surgery : a review of 81 cases]. Ophthalmologe (2009) 0.82
Inhibitory effect of PACAP-38 on acute neurogenic and non-neurogenic inflammatory processes in the rat. Peptides (2007) 0.82
Ventricular overdrive pacing-induced preconditioning and no-flow ischemia-induced preconditioning in isolated working rat hearts. J Cardiovasc Pharmacol (1995) 0.82
Effect of L-aminocarnitine, an inhibitor of mitochondrial fatty acid oxidation, on the exocrine pancreas and liver in fasted rats. Pharmacol Res (2000) 0.82
Stimulated gastrointestinal hormone release and gallbladder contraction during continuous jejunal feeding in patients with pancreatic pseudocyst is inhibited by octreotide. Int J Pancreatol (2000) 0.82
Effects of PACAP on intracellular signaling pathways in human retinal pigment epithelial cells exposed to oxidative stress. J Mol Neurosci (2012) 0.82
Rescuing neurons and glia: is inhibition of apoptosis useful? Prog Brain Res (2007) 0.81
Comparative study of the effects of PACAP in young, aging, and castrated males in a rat model of Parkinson's disease. Ann N Y Acad Sci (2006) 0.81
Direct myocardial anti-ischaemic effect of GTN in both nitrate-tolerant and nontolerant rats: a cyclic GMP-independent activation of KATP. Br J Pharmacol (1999) 0.81
Concentrations of pituitary adenylate cyclase activating polypeptide (PACAP) in human brain nuclei. Brain Res (1995) 0.81
Effects of the somatostatin receptor subtype 4 selective agonist J-2156 on sensory neuropeptide release and inflammatory reactions in rodents. Br J Pharmacol (2006) 0.81
Effects of pituitary adenylate cyclase activating polypeptide on the survival and signal transduction pathways in human choriocarcinoma cells. Ann N Y Acad Sci (2009) 0.81
KATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide. Cardiovasc Res (1995) 0.81
Specific antibody recognition of rat pituitary adenylate cyclase activating polypeptide receptors. Endocrine (1997) 0.80
Moderate stress by cardiac pacing may induce both short term and long term cardioprotection. Cardiovasc Res (1993) 0.80
Impaired nocifensive behaviours and mechanical hyperalgesia, but enhanced thermal allodynia in pituitary adenylate cyclase-activating polypeptide deficient mice. Neuropeptides (2010) 0.80
Systemic anti-inflammatory effect of somatostatin released from capsaicin-sensitive vagal and sciatic sensory fibres of the rat and guinea-pig. Eur J Pharmacol (2000) 0.80
Effect of PACAP in 6-OHDA-induced injury of the substantia nigra in intact young and ovariectomized female rats. Neuropeptides (2006) 0.80
Nitroglycerin-induced direct protection of the ischaemic myocardium in isolated working hearts of rats with vascular tolerance to nitroglycerin. Br J Pharmacol (1995) 0.80
Changes in open-field activity and novelty-seeking behavior in periadolescent rats neonatally treated with monosodium glutamate. Neurotox Res (2007) 0.80
Effect of PACAP treatment on kidney morphology and cytokine expression in rat diabetic nephropathy. Peptides (2013) 0.80
Protective effects of vasoactive intestinal peptide (VIP) in ischemic retinal degeneration. J Mol Neurosci (2012) 0.79
The origin and ultrastructural characteristics of corticotropin-releasing factor (CRF)-immunoreactive nerve fibers in the posterior pituitary of the rat. Cell Tissue Res (1985) 0.79
Cone function in children with a history of preterm birth. Doc Ophthalmol (2011) 0.79
The effect of micronised fenofibrate on paraoxonase activity in patients with coronary heart disease. Diabetes Metab (2003) 0.79
Rapid increase in plasma IL-6 after hemorrhage, and posthemorrhage reduction of the IL-6 response to LPS, in conscious rats: interrelation with plasma corticosterone levels. Neuroimmunomodulation (1996) 0.79
Immunohistochemical localization of the neuropeptide, pituitary adenylate cyclase activating polypeptide (PACAP), in human and primate hypothalamus. Peptides (1991) 0.79
Biologic blood markers reflecting thyroid hormone effect at peripheral tissue level in patients receiving levothyroxine replacement for hypothyroidism. Acta Med Hung (1991) 0.79
Cytochemical characterization of anterior pituitary target cells for the neuropeptide, pituitary adenylate cyclase activating polypeptide (PACAP), using biotinylated ligands. Peptides (1993) 0.79
Pituitary adenylate cyclase activating polypeptide is highly abundant in the nervous system of anoxia-tolerant turtle, Pseudemys scripta elegans. Peptides (2001) 0.79
Capsaicin-insensitive sensory-efferent meningeal vasodilatation evoked by electrical stimulation of trigeminal nerve fibres in the rat. Br J Pharmacol (1999) 0.79
Comparative investigations on vitamin A level of plasma in some rheumatic diseases. Clin Rheumatol (1986) 0.78
Changes in the expression of pituitary adenylate cyclase-activating polypeptide in the human placenta during pregnancy and its effects on the survival of JAR choriocarcinoma cells. J Mol Neurosci (2010) 0.78
Gender differences in age-related physiological changes and some diseases. Z Gerontol Geriatr (1995) 0.78